On February 3, the final workshop of the European Smart4Fabry project will be held. Smart4Fabry is an initiative whose objective is to obtain a new GLA nanoformulation to address Fabry disease, achieving relevant improvements on the efficacy and tolerance of the treatments based on enzyme replacement therapies. Our technology transfer director Alba Córdoba will lead the session dealing with Production Optimization and Scale-up of the nanoformulation and our CEO Santi Sala will contribute to the final round table.

Online venue:

Further relevant information regarding the event will be provided on https://smart4fabry.eu/

Subscribe to Directory
Write an Article

Recent News

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

El diagnóstico genético neonatal mejor...

Un estudio con datos de los últimos 35 años, ind...

Más de 1.500 cambios epigenéticos en e...

Un equipo de investigadores de la Universidad Juli...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Horizon pone en marcha una planta punter...

by Horizon Products

Horizon ha puesto en funcionamiento una nueva planta dedicada íntegra...

Photos Stream